MedPath
PPB Approval

TYSABRI CONCENTRATE FOR SOLUTION FOR INFUSION 300MG

HK-61519

Prescription only Medicines

November 12, 2012

Company Information

Company Details

FLAT/RM A, 29/F, LEE & MAN COMMERCIAL CENTER, 169 ELECTRIC ROAD, NORTH POINT, HONG KONG

Active Ingredients

natalizumab

Drug Monographs

Natalizumab

那他珠单抗

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.